Pleiotropic Defects of IL‐6—deficient Mice Including Early Hematopoiesis, T and B Cell Function, and Acute Phase Responses

Annals of the New York Academy of Sciences

Volumn 762, Issue 1, 1995, Pages 308-318

  KOPF, MANFRED ^a   RAMSAY, ALISTAIR ^b   BROMBACHER, FRANK ^a   BAUMANN, HEINZ ^c   FREER, GIULIA ^d   GALANOS, CHRIS ^a   GUTIERREZ‐RAMOS, JOSE‐CARLOS ^e   KÖHLER, GEORGES ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ACUTE PHASE RESPONSE; B LYMPHOCYTE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; COLONY FORMING UNIT; CONFERENCE PAPER; EMBRYO DEVELOPMENT; GENE DISRUPTION; HEMATOPOIESIS; INFECTION; PLEIOTROPY; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS; SEPTIC SHOCK; STEM CELL; T LYMPHOCYTE; TISSUE INJURY;

EID: 0029146342     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb32335.x     Document Type: Article

References (43)

1. Interleukin‐6: An overview
2. The biology of interleukin‐6
3. IL6 and the T‐cell response
4. Interleukin 6 enhancement of interleukin 3‐dependent proliferation of multipotential hemopoietic progenitors
5. Synergistic factors for stem cell proliferation: Further studies of the target stem cells and the mechanism of stimulation by interleukin‐1, interleukin‐6, and granulocyte colony‐stimulating factor
6. Recombinant human interleukin 6 (B‐cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1)
7. Interleukin‐6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely‐moving rats
8. Interleukin‐6 stimulates anterior pituitary hormone release in vitro
9. The acute phase protein response during parasitic infection
10. Interleukin‐6 and its receptor: A paradigm for cytokines
11. Impaired immune and acute‐phase responses in interleukin‐6‐deficient mice
12. Leukemia inhibitory factor is necessary for the maintenance of haematopoietic sem cells and thymocyte stimulation
13. The genes for leukemia inhibitory factor and interleukin‐6 are expressed in mouse blastocysts prior to the onset of hemopoiesis
14. Gene expression during preimplantation mouse development
15. Trophoblast derived IL‐6 regulates human chorionic gonadotropin release through IL‐6 receptor on human trophoblasts
16. Unusually large interferon‐alpha‐like mRNAs and high expression of interleukin‐6 in human fetal annexes
17. Blastocyst implantation depends on maternal expression of leukae‐mia inhibitory factor
18. The renewal and differentiation of hemopoietic stem cells
19. IL‐6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system
20. T cell growth and differentiation induced by interleukin‐HPI/IL‐6, the murine hybridoma/plasmacytoma growth factor
21. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes
22. A case for cytokines as effector molecules in the resolution of virus infection
23. β2‐microglobulin‐, CD8 + T cell deficient mice survive high doses of vaccinia virus and exhibit altered IgG responses
24. Complementary DNA for a novel human interleukin (BSF‐2) that induces B lymphocytes to produce immunoglobulin
25. Interleulcin‐HP1, a T cell‐derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas
26. IgG1 plasmacytosis in interleukin‐6 transgenic mice
27. Overview of the mucosal immune system
28. Interleukins and IgA synthesis
29. The role of interleukin‐6 in mucosal IgA antibody responses in vivo
30. Endotoxins and disease mechanisms
31. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
32. Interferon gamma receptor deficient mice are resistant to endotoxic shock
33. Role of interleukin‐1 in infectious diseases
34. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
35. Interleukin 10 protects mice from lethal endotoxemia
36. Requirement for lipopolysaccharide‐responsive macrophages in galactosamine‐induced sensitization to endotoxin
37. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
38. Cell‐mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor
39. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response
40. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice
41. Limited involvement of interleukin‐6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin‐6 or its receptor in various murine models